0000874015-23-000226.txt : 20231218 0000874015-23-000226.hdr.sgml : 20231218 20231218165542 ACCESSION NUMBER: 0000874015-23-000226 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231214 FILED AS OF DATE: 20231218 DATE AS OF CHANGE: 20231218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BENNETT C FRANK CENTRAL INDEX KEY: 0001073387 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 231494494 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT STREET 2: C/O IONIS PHARMACEUTICALS, INC. CITY: CARLSBAD STATE: CA ZIP: 92010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330336973 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 FORMER COMPANY: FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2023-12-14 0 0000874015 IONIS PHARMACEUTICALS INC IONS 0001073387 BENNETT C FRANK 2855 GAZELLE COURT CARLSBAD CA 92010 0 1 0 0 EVP, Chief Scientific Officer 1 Common Stock 2023-12-14 4 M 0 14002 47.34 A 79756 D Common Stock 2023-12-14 4 S 0 14002 49.2133 D 65754 D Common Stock 2023-12-14 4 M 0 8610 47.34 A 74364 D Common Stock 2023-12-14 4 S 0 8610 50.187 D 65754 D Non-Qualified Stock Option (right to buy) 47.34 2023-12-14 4 M 0 14002 0.0 D 2018-01-03 2024-01-02 Common Stock 14002 31223 D Non-Qualified Stock Option (right to buy) 47.34 2023-12-14 4 M 0 8610 0.0 D 2018-01-03 2024-01-02 Common Stock 8610 22613 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.75 to $49.75 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) on this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.50 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4. By: Patrick R. O'Neil, attorney-in-fact For: C. Frank Bennett 2023-12-15